1. Home
  2. IZEA vs ICCC Comparison

IZEA vs ICCC Comparison

Compare IZEA & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

HOLD

Current Price

$4.62

Market Cap

69.1M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$5.96

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IZEA
ICCC
Founded
2006
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
55.5M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
IZEA
ICCC
Price
$4.62
$5.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
58.8K
34.6K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$36,176,492.00
$27,769,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
N/A
P/E Ratio
N/A
$23.82
Revenue Growth
7.12
16.49
52 Week Low
$1.68
$4.28
52 Week High
$5.86
$7.60

Technical Indicators

Market Signals
Indicator
IZEA
ICCC
Relative Strength Index (RSI) 47.16 52.72
Support Level $4.30 $6.01
Resistance Level $4.56 $7.12
Average True Range (ATR) 0.17 0.33
MACD -0.02 0.01
Stochastic Oscillator 44.59 24.68

Price Performance

Historical Comparison
IZEA
ICCC

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: